Breast Cancer
Feature
Cancer screening, monitoring down during pandemic
Use of some tests came to “a near standstill” in early April.
Conference Coverage
Adding a blood test to standard screening may improve early cancer detection
Conference Coverage
Novel immune activator boosts immunotherapy benefit in TNBC
From the Journals
Excess cancer deaths predicted as care is disrupted by COVID-19
Conference Coverage
Antitumor treatment may increase risk of severe events in COVID-19 patients
Conference Coverage
EMBRACA shows no overall survival benefit with talazoparib
Talazoparib did not confer an overall survival benefit over chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast...
Conference Coverage
Metastatic cancer linked to worse outcomes of COVID-19
Conference Coverage
Novel combo boosts response in HER2-negative breast cancer
Guidelines
ESMO gets creative with guidelines for breast cancer care in the COVID-19 era
Feature
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Feature
Will coronavirus restrictions lead to more advanced cancers?